Modulating Default Mode Network Function: A Transcranial Direct Current Stimulation (TDCS) Pilot Study (MDMN)
調査の概要
詳細な説明
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Pennsylvania
-
Pittsburgh、Pennsylvania、アメリカ、15213
- University of Pittsburgh
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Between 18-30years old
- Score > 10 on the QIDS or > 60 on the PROMIS-A
- We will use a flexible extreme groups recruitment strategy to ensure an adequate distribution of ESC scores. We will ensure that at least 62% of the sample will be composed of those scoring .5 SD above or below the mean, as measured by the NEO-PI-R. This value corresponds to the expected values assuming a normal distribution of the trait.
- Normal or corrected to normal vision with contact lenses
- Able to provide informed consent in English
- Right-handed (Annett criteria)
Exclusion Criteria:
- Have a history of head trauma with loss of consciousness.
- Have a systemic medical illness that may impact fMRI measures of cerebral blood flow.
- Meet standard exclusion criteria for fMRI scanning (e.g. claustrophobia, cardiac pacemakers, neural pacemakers, surgically implanted metal devices, cochlear implants, metal braces, or other MRI non-safe metal objects in the body).
- Are pregnant (self report and tested for as part of any scan by the scanning center and not this protocol)
- Not native English speaking or not fluent
- Premorbid NAART IQ estimate<85;
- Visual disturbance (worse than 20/40 Snellen visual acuity) that is not corrected
- If have visual disturbance, only access to correction with glasses (i.e., no access to contact lenses).
- Left/mixed handedness (Annett criteria), to ensure a uniform hemispheric dominance for interpretation of neuroimaging data
- Active suicidal ideation in need of immediate treatment
- Scoring below the cutoffs on both the QIDS and the PROMIS-A
- History of alcohol/substance use disorder (including nicotine) and/or illicit substance use (except cannabis) over the last 3 months, determined by the MINI. Lifetime/present cannabis use (non-disordered levels) will be allowed, given its common usage in individuals in this age range.
- Current or past psychotic-spectrum disorder
- History of seizures
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
実験的:Transcranial Direct Current Stimulation during fMRI
Each subject will undergo transcranial direct current stimulation twice while completing a task in the functional magnetic resonance imaging scanner.
|
TDCS involves passing a weak current through the brain.
One variant, cathodal TDCS, can be used to temporarily hyperpolarize cortical pyramidal cells, thereby decreasing neuronal connections.
TDCS has been explored as a possible treatment for depression, but results to date are mixed.
No work has examined whether TDCS can be used in an individually guided manner to target locations in the parietal cortex and alter the patterns of circuitry dysfunction described previously.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Blood Oxygen Level Dependent (BOLD) Response in the Precuneus During an Emotion Regulation Task Completed During fMRI Scanning.
時間枠:1 week (between baseline and repeat scanning)
|
The investigators will determine the effects of TDCS on BOLD response in the precuneus/posterior cingulate gyrus. The BOLD signal is a measure of regional blood flow in the brain and is used as a proxy for neural activity in specific brain regions. Values below represent pre-post change in BOLD response to the emotion regulation task that participants complete during fMRI scanning. We hypothesize that tDCS applied to the target used in this study will decrease BOLD signal (lower values) during critical components of this task, normalizing function in this region. |
1 week (between baseline and repeat scanning)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
The Percentage of Patients Who Reported a Side Effect in the Active tDCS Condition But Not the Sham tDCS Condition
時間枠:30 minutes to 1 hour (the period during which the tDCS device was worn) on each of two scan days
|
Potential side effects (e.g., headaches, dizziness, uncomfortable sensations, etc...) will be assessed after each tDCS and sham-tDCS administration. Side effects were assessed using a standardized form. Count below represents the number of participants who reported a mild or moderate side effect during active tDCS but not sham tDCS. |
30 minutes to 1 hour (the period during which the tDCS device was worn) on each of two scan days
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Jay C Fournier, Ph. D.、University of Pittsburgh
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
TDCS - transcranial direct current stimulationの臨床試験
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)完了